These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 21697000)

  • 1. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients.
    Supić G; Kozomara R; Branković-Magić M; Jović N; Magić Z
    Oral Oncol; 2009 Dec; 45(12):1051-7. PubMed ID: 19665921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.
    Su PF; Huang WL; Wu HT; Wu CH; Liu TY; Kao SY
    Oral Oncol; 2010 Oct; 46(10):734-9. PubMed ID: 20729138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected close surgical margin in resected buccal cancer: very close margin and DAPK promoter hypermethylation predict poor clinical outcomes.
    Lin HY; Huang TT; Lee MS; Hung SK; Lin RI; Tseng CE; Chang SM; Chiou WY; Hsu FC; Hsu WL; Liu DW; Su YC; Li SC; Chan MW
    Oral Oncol; 2013 Apr; 49(4):336-44. PubMed ID: 23245584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.
    Shaw RJ; Hobkirk AJ; Nikolaidis G; Woolgar JA; Triantafyllou A; Brown JS; Liloglou T; Risk JM
    Ann Surg Oncol; 2013 Aug; 20(8):2796-802. PubMed ID: 23111707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
    Zhang S; Kong WJ
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
    Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue.
    Sinha P; Bahadur S; Thakar A; Matta A; Macha M; Ralhan R; Gupta SD
    Head Neck; 2009 Nov; 31(11):1423-30. PubMed ID: 19431196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix.
    Dong SM; Kim HS; Rha SH; Sidransky D
    Clin Cancer Res; 2001 Jul; 7(7):1982-6. PubMed ID: 11448914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of RASSF1A, RARbeta and DAPK predict poor prognosis of patients with malignant mesothelioma.
    Fischer JR; Ohnmacht U; Rieger N; Zemaitis M; Stoffregen C; Kostrzewa M; Buchholz E; Manegold C; Lahm H
    Lung Cancer; 2006 Oct; 54(1):109-16. PubMed ID: 16893590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa.
    Paluszczak J; Misiak P; Wierzbicka M; Woźniak A; Baer-Dubowska W
    Oral Oncol; 2011 Feb; 47(2):104-7. PubMed ID: 21147548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
    Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT; Lee SH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.